Advertisement
Advertisement
U.S. markets close in 4 hours 36 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Surface Oncology, Inc. (SURF)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.0900-0.0700 (-6.03%)
As of 11:23AM EDT. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Surface Oncology to Present Preclinical Data Highlighting the IL-27 Gene Expression Signature in Treatment-Resistant Cancers at the 10th Annual International Cytokine and Interferon Society Meeting

    - New preclinical data indicate IL-27 induces a gene expression signature that has been associated with resistance to chemotherapy, radiotherapy, and checkpoint inhibition - - Findings support the ongoing clinical investigation of SRF388 in multiple tumor types - CAMBRIDGE, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that the c

  • GlobeNewswire

    Surface Oncology to Participate in the Baird 2022 Global Healthcare Conference

    CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Wednesday, September 14, 2022, at 10:15 a.m. ET. A live webcast of the presentation may be accessed by visiting the Investors & Media section

  • GlobeNewswire

    Surface Oncology to Participate in the Gilmartin Group Emerging Growth Company Showcase

    CAMBRIDGE, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the virtual Gilmartin Group Emerging Growth Company Showcase on Wednesday, August 31, 2022 at 2:30 p.m. ET. A live webcast of the presentation may be accessed by visiting the Investors & Med

Advertisement
Advertisement